DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Frick MH, Elo O, Haapa K. et al.
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia - safety of treatment, changes in risk factors, and incidence of coronary heart disease.
N Engl J Med 1987; 317: 1237-1245
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.